Citations - Lax Sigurd

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial

BACKGROUND: Relapsed or refractory follicular lymphoma (rrFL) is an incurable disease associated with shorter remissions and survival after each line of standard therapy. Many promising novel, chemotherapy-free therapies are in development, but few are licensed as their role in current treatment pathways is poorly defined.... Read more

Published on: 2024-03-26

Source: Lax Sigurd

By: Graham McIlroy

A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids

No abstract... Read more

Published on: 2024-02-17

Source: Lax Sigurd

By: Aaron M Drucker